Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold
its Annual General Meeting (AGM) on April 28, 2021.
As a result of the continuing exceptional circumstances due to
the coronavirus (COVID-19) pandemic, the 2021 AGM will be held
without the personal attendance of shareholders and shareholders
will not be granted access to the meeting room, in accordance with
the Ordinance of the Swiss Federal Council regarding measures on
combating the coronavirus (COVID-19) as amended on March 1, 2021
(COVID-19 Ordinance 3). Accordingly, and in accordance with the
COVID-19 Ordinance 3, shareholders shall exercise their rights at
our AGM exclusively by sending in voting instructions to the
independent representative identified in the voting materials.
The invitation to the AGM, including explanatory information on
individual agenda items, will be available online beginning March
25, 2021 at
https://investor.alcon.com/news-and-events/events-and-presentations/event-details/2021/2021-Annual-General-Meeting/default.aspx.
Agenda for Alcon’s
2021 AGM
1. Approval of the operating and financial review of Alcon Inc.,
the annual financial statements of Alcon Inc. and the consolidated
financial statements for 2020
2. Discharge of the members of the Board of Directors and the
members of the Executive Committee
3. Appropriation of earnings and declaration of dividend as per
the balance sheet of Alcon Inc. of December 31, 2020
- If approved by the shareholders, a dividend of CHF 0.10 in cash
per share will be payable with the first trading day ex-dividend
expected to be May 4, 2021 record date expected to be May 5, 2021
and the payout date in Switzerland expected to be on or around May
6, 2021. The Swiss withholding tax of 35% will be deducted from the
gross dividend amount.
4. Votes on the compensation of the Board of Directors and of
the Executive Committee
4.1 Consultative vote on the 2020
Compensation Report
4.2 Binding vote on the maximum aggregate
amount of compensation of the Board of Directors for the next term
of office, i.e. from the 2021 Annual General Meeting to the 2022
Annual General Meeting
4.3 Binding vote on the maximum aggregate
amount of compensation of the Executive Committee for the following
financial year, i.e. 2022
5. Re-election of the Chair and the Members of the Board of
Directors
5.1 Re-election of F. Michael Ball (as Member
and Chair)
5.2 Re-election of Lynn D. Bleil (as
Member)
5.3 Re-election of Arthur Cummings (as
Member)
5.4 Re-election of David J. Endicott (as
Member)
5.5 Re-election of Thomas Glanzmann (as
Member)
5.6 Re-election of D. Keith Grossman (as
Member)
5.7 Re-election of Scott Maw (as Member)
5.8 Re-election of Karen May (as Member)
5.9 Re-election of Ines P�schel (as
Member)
5.10 Re-election of Dieter Spälti (as
Member)
6. Re-election of the members of the Compensation Committee
6.1 Re-election of Thomas Glanzmann
6.2 Re-election of D. Keith Grossman
6.3 Re-election of Karen May
6.4 Re-election of Ines P�schel
7. Re-election of the independent representative
8. Re-election of the statutory auditors
Cautionary Note Regarding
Forward-Looking Statements
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,”
“seek,” “target,” “assume,” “believe,” “project,” “estimate,”
“expect,” “strategy,” “future,” “likely,” “may,” “should,” “will”
and similar references to future periods. An example of a
forward-looking statement includes, among others, statements Alcon
makes regarding the payment of a dividend.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. Should one or more of these
uncertainties or risks materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated. Therefore, you should not rely on any of
these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date they are made, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 23,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210324005965/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jul 2023 to Jul 2024